LPL Financial
RARE icon

LPL Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History

LPL Financial’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,840
Closed -$358K – 5961
2025
Q2 		$358K Buy
9,840
+327
+3% +$11.8K ﹤0.01% 4643
2025
Q1 		$344K Buy
9,513
+1,430
+18% +$59.5K ﹤0.01% 4481
2024
Q4 		$340K Sell
8,083
-287
-3% -$14.2K ﹤0.01% 4408
2024
Q3 		$465K Buy
8,370
+2,299
+38% +$117K ﹤0.01% 4057
2024
Q2 		$250K Sell
6,071
-1,131
-16% -$48.3K ﹤0.01% 4400
2024
Q1 		$336K Sell
7,202
-12
-0.2% -$566 ﹤0.01% 4109
2023
Q4 		$345K Sell
7,214
-179
-2% -$6.94K ﹤0.01% 3984
2023
Q3 		$264K Sell
7,393
-41
-0.6% -$1.62K ﹤0.01% 4027
2023
Q2 		$343K Buy
7,434
+1,446
+24% +$67.1K ﹤0.01% 3736
2023
Q1 		$240K Buy
5,988
+127
+2% +$5.45K ﹤0.01% 3912
2022
Q4 		$272K Buy
+5,861
New +$231K ﹤0.01% 3725
2022
Q3 		– Sell
-5,412
Closed -$323K – 4497
2022
Q2 		$323K Buy
5,412
+3
+0.1% +$185 ﹤0.01% 3571
2022
Q1 		$393K Buy
5,409
+2,457
+83% +$171K ﹤0.01% 3372
2021
Q4 		$248K Buy
2,952
+537
+22% +$43.7K ﹤0.01% 3833
2021
Q3 		$218K Buy
2,415
+22
+0.9% +$1.99K ﹤0.01% 3904
2021
Q2 		$228K Sell
2,393
-289
-11% -$30.1K ﹤0.01% 3809
2021
Q1 		$305K Buy
2,682
+15
+0.6% +$2.04K ﹤0.01% 3459
2020
Q4 		$369K Buy
+2,667
New +$316K ﹤0.01% 3035

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

LPL Financial's RARE Position: Q3 2025 in Review

LPL Financial sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2025, closing a stake of 9,840 shares — an estimated $358K sold.

LPL Financial first reported a position in RARE in Q4 2020 and held it in 18 quarters. The position peaked at $465K in Q3 2024. 302 funds tracked by Wall St. Rank hold RARE as of Q3 2025.

  • LPL Financial reported no remaining Ultragenyx Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • LPL Financial sold 9,840 Ultragenyx Pharmaceutical shares in Q3 2025, an estimated $358K.
  • LPL Financial first reported a position in Ultragenyx Pharmaceutical in Q4 2020 and held it in 18 quarters.
  • LPL Financial's Ultragenyx Pharmaceutical position peaked at $465K in Q3 2024.
  • 302 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2025.

Based on LPL Financial's 13F filing for Q3 2025, filed 12 Nov 2025.